BE372883A - - Google Patents
Info
- Publication number
- BE372883A BE372883A BE372883DA BE372883A BE 372883 A BE372883 A BE 372883A BE 372883D A BE372883D A BE 372883DA BE 372883 A BE372883 A BE 372883A
- Authority
- BE
- Belgium
- Prior art keywords
- extract
- temperature
- glands
- precipitant
- water
- Prior art date
Links
- 210000004907 gland Anatomy 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 230000001054 cortical effect Effects 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 235000019441 ethanol Nutrition 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 210000004100 adrenal gland Anatomy 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 230000029087 digestion Effects 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 239000006286 aqueous extract Substances 0.000 claims 1
- 239000000470 constituent Substances 0.000 claims 1
- 125000005909 ethyl alcohol group Chemical group 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 229910052573 porcelain Inorganic materials 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- -1 dilute acetic acid Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE372883A true BE372883A (OSRAM) |
Family
ID=43918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE372883D BE372883A (OSRAM) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE372883A (OSRAM) |
-
0
- BE BE372883D patent/BE372883A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1052307A (fr) | Procede d'extraction et de traitement de glycoproteines, de mucopolysaccharides et de substances qui les accompagnent | |
| FR2487674A1 (fr) | Produit cosmetique presentant des effets de regeneration sur la peau et les muscles et procede pour la preparation de ce produit cosmetique | |
| BE372883A (OSRAM) | ||
| CN114306163A (zh) | 一种具有美白功效的三叶鬼针草提取物的制备方法和应用 | |
| FR2509176A1 (fr) | Procede pour produire une preparation de tissus biologiques pour la therapie et la regeneration de cellules d'organismes vivants | |
| Bell | A Treatise on the Theory and Management of Ulcers | |
| FR2500305A1 (fr) | Procede de preparation d'un extrait de sperme, extrait obtenu selon ce procede et son utilisation notamment en therapeutique et en cosmetique | |
| WO2020030566A1 (fr) | Inhalateur nasal pour le traitement des symptômes liés aux infections des voies respiratoires supérieures | |
| WO1991016036A1 (fr) | Compositions cosmetiques contenant un extrait d'une zygophyllacee appartenant au genre larrea | |
| EP0423262A1 (de) | Proteinfraktion aus dem photosyntheseapparat von pflanzen zur anwendung als wirkstoff zur selektiven auflösung von krebszellen und zur nachbehandlung von narben, keloiden und entzündlichen prozessen sowie diese enthaltende pharmazeutische erzeugnisse. | |
| KR100430436B1 (ko) | 프로폴리스 추출물이 함유된 럼의 제조 방법 | |
| EA005009B1 (ru) | Способ получения экстракта растения cyclamen europaeum l. и его применение для получения лекарственного средства для лечения синусита | |
| US1771976A (en) | Therapeutic substance and method of preparing the same | |
| Faisal et al. | The effect of phenolic extract of mint (Mentha spicata) in the fertility of male laboratory mice | |
| DE623392C (OSRAM) | ||
| US2045266A (en) | Production of liver extract | |
| FR2687318A1 (fr) | Composition nouvelle, a base de substances naturelles utilisables en therapeutique dermatologique ainsi que son procede de preparation. | |
| KR100430434B1 (ko) | 프로폴리스 추출물이 함유된 과일주의 제조방법 | |
| Khudier et al. | The Effect of Low Dose Capsaicin on Ovarian Histological Structure in Induced Polycystic Ovary Syndrome in Adult Rats | |
| EP0987941B1 (fr) | Perfectionnement aux procedes de preparation d'embryons d'equides en vue de leur cryoconservation | |
| AT136721B (de) | Verfahren zur Herstellung eines das Wachstum von Geschwülsten hemmenden Stoffes. | |
| BE475216A (OSRAM) | ||
| JPH01187071A (ja) | くまざさより生エキスの製造法 | |
| FR2857872A1 (fr) | Utilisation du noni lors de pathologie bucco dentaires notamment pour combattre les problemes d'asialie et d'hyposialie | |
| DE845485C (de) | Verfahren zur Herstellung von Magenschleimhautpraeparaten durch Selbstandauung |